The penile cancer treatment market is projected to grow from USD 3.7 billion in 2025 to USD 13.8 billion by 2035, at a CAGR of 14.0%. Squamous cell cancer of penis will dominate with a 30.1% market share, while surgery (cryosurgery, laser) will lead the type of therapy segment with a 36.2% share.